Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
8 August 2014
Header
Header image
From our blog

From our blog

Smart spending on healthcare
07 August 2014 by Richard Torbett

Many commentators are asking whether society can continue to support innovation in a way that publicly funded health systems can afford. My very clear view [...] Read more

Events calendar

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference - Predictions 2020: The Future of the Industry
From 17/11/2014 to 18/11/2014 (London, UK )

The future is arriving fast for the life science industry. Convergence is happening along the entirety of the industry value chain, blurring the boundaries between pharma, biotech, [...] Read more

What we are reading

What we are reading

Daily aspirin 'cuts bowel and stomach cancer deaths'
08 August 2014

British researchers say aspirin could reduce the risk of developing - or dying from - certain types of cancer.

Read more

What we are reading

In search for Alzheimer's drug, a major STEP forward
08 August 2014 (http://medicalxpress.com/news/2014-08-alzheimer-drug-major.html)

Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer's disease in an animal model.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail